Painchek Ltd (PCK) - Total Assets
Based on the latest financial reports, Painchek Ltd (PCK) holds total assets worth AU$2.15 Million AUD (≈ $1.52 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See PCK net assets for net asset value and shareholders' equity analysis.
Painchek Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Painchek Ltd's total assets have evolved over time, based on quarterly financial data.
Painchek Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Painchek Ltd's total assets of AU$2.15 Million consist of 99.1% current assets and 0.9% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 75.2% |
| Accounts Receivable | AU$446.02K | 20.8% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$19.54K | 0.9% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Painchek Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PCK stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Painchek Ltd's current assets represent 99.1% of total assets in 2025, an increase from 88.6% in 2011.
- Cash Position: Cash and equivalents constituted 75.2% of total assets in 2025, down from 82.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 20.8% of total assets.
Painchek Ltd Competitors by Total Assets
Key competitors of Painchek Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pathkey.ai Ltd
AU:PKY
|
Australia | AU$513.28K |
|
Adheris Health Limited
AU:AHE
|
Australia | AU$39.84 Million |
|
SMAIO SA
PA:ALSMA
|
France | €14.11 Million |
|
Reliq Health Technologies Inc
V:RHT
|
Canada | CA$22.29 Million |
|
Emyria Ltd
AU:EMD
|
Australia | AU$6.62 Million |
|
Careteq Ltd
AU:CTQ
|
Australia | AU$4.44 Million |
|
Brain+ ApS
CO:BRAINP
|
Denmark | Dkr35.35 Million |
|
Tali Digital Ltd
AU:TD1
|
Australia | AU$2.77 Million |
Painchek Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.65 | 1.44 | 2.97 |
| Quick Ratio | 0.65 | 1.49 | 2.97 |
| Cash Ratio | 0.00 | 1.23 | 2.93 |
| Working Capital | AU$-1.13 Million | AU$1.26 Million | AU$4.11 Million |
Painchek Ltd - Advanced Valuation Insights
This section examines the relationship between Painchek Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 37.90 |
| Latest Market Cap to Assets Ratio | 9.63 |
| Asset Growth Rate (YoY) | -48.6% |
| Total Assets | AU$2.15 Million |
| Market Capitalization | $20.70 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Painchek Ltd's assets at a significant premium (9.63x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Painchek Ltd's assets decreased by 48.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Painchek Ltd (2011–2025)
The table below shows the annual total assets of Painchek Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$2.15 Million ≈ $1.52 Million |
-48.60% |
| 2024-06-30 | AU$4.18 Million ≈ $2.96 Million |
+49.62% |
| 2023-06-30 | AU$2.80 Million ≈ $1.98 Million |
-57.98% |
| 2022-06-30 | AU$6.65 Million ≈ $4.71 Million |
-43.68% |
| 2021-06-30 | AU$11.81 Million ≈ $8.36 Million |
+90.02% |
| 2020-06-30 | AU$6.22 Million ≈ $4.40 Million |
+30.87% |
| 2019-06-30 | AU$4.75 Million ≈ $3.36 Million |
+29.32% |
| 2018-06-30 | AU$3.67 Million ≈ $2.60 Million |
+36.54% |
| 2017-06-30 | AU$2.69 Million ≈ $1.90 Million |
+2245.38% |
| 2016-06-30 | AU$114.69K ≈ $81.15K |
-95.09% |
| 2015-06-30 | AU$2.34 Million ≈ $1.65 Million |
+143.45% |
| 2014-06-30 | AU$959.92K ≈ $679.20K |
-31.06% |
| 2013-06-30 | AU$1.39 Million ≈ $985.18K |
-42.59% |
| 2012-06-30 | AU$2.43 Million ≈ $1.72 Million |
+989.97% |
| 2011-06-30 | AU$222.50K ≈ $157.43K |
-- |
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more